Go Back to Match Results for ""

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma With Preserved Liver Function. HCRN: GI15-225
Recruitment Status
OpenContact the research team to learn more about this study.
Fields marked with asterisk (*) are required